why choose us

First received: January 17, 2024

Clinical Trial: Studies Evaluating the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of TY-9591 Tablets in Healthy Subjects

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: NSCLC

Study Type: INTERVENTIONAL


Official Title: This is a Single-center, Two-sequence, Open-label, Two-cycle Drug-drug Interaction (DDI) Study in Healthy Subjects. To Evaluate the Effects of Itraconazole Capsules, a Strong Inhibitor of CYP3A4, and

Brief Summary: Studies evaluating the effects of itraconazole or rifampicin on the pharmacokinetics of TY-9591 tablets in healthy subjects

Read more